Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Long-Term Investments (2022)

Medicinova (MNOV) has disclosed Long-Term Investments for 4 consecutive years, with $10.0 million as the latest value for Q3 2022.

  • Quarterly Long-Term Investments changed N/A to $10.0 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Sep 2022, changed N/A year-over-year, with the annual reading at $680982.0 for FY2013, 2.07% up from the prior year.
  • Long-Term Investments for Q3 2022 was $10.0 million at Medicinova, up from $690328.0 in the prior quarter.
  • The five-year high for Long-Term Investments was $10.0 million in Q3 2022, with the low at $10.0 million in Q3 2022.